JOHN R MOORE Insider Trading $ARRY ARRAY BIOPHARMA INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JOHN R MOORE.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JOHN R MOORE. JOHN R MOORE is VP AND GENERAL COUNSEL in ARRAY BIOPHARMA INC ($ARRY) and VP, General Counsel in ARRAY BIOPHARMA INC ($ARRY) and Director in Nivalis Therapeutics, Inc. ($NVLS).

JOHN R MOORE in ARRAY BIOPHARMA INC

Trading Symbol: ARRY
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN R MOORE: VP, General Counsel, VP AND GENERAL COUNSEL
Holdings: 46,472 shares
Current Value: $489,350
Latest Transaction: Apr 04 2017
$ARRY Market Capitalization: $1.80B
$ARRY Previous Close: $10.53

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of JOHN R MOORE in ARRAY BIOPHARMA INC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ALPN, ARRY

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 04 2017	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	M	0.00	6,718	0	20,157
Apr 04 2017	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Payment of Exercise	F	8.94	4,408	39,408	42,064	46.5 K to 42.1 K (-9.49 %)
Apr 04 2017	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Buy	M	0.00	6,718	0	46,472	39.8 K to 46.5 K (+16.90 %)
Dec 29 2016	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	8.79	131,250	1,153,688	131,250
Dec 29 2016	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	0.00	21,875	0	21,875
Apr 05 2016	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	3.00	161,250	483,750	161,250
Apr 05 2016	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	0.00	26,875	0	26,875
Apr 05 2016	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Payment of Exercise	F	3.00	2,505	7,515	39,754	42.3 K to 39.8 K (-5.93 %)
Apr 03 2015	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	7.30	161,250	1,177,125	161,250
Apr 03 2015	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Grant	A	0.00	26,875	0	42,259	15.4 K to 42.3 K (+174.69 %)
Mar 04 2015	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	M	0.00	22,906	0	22,906
Mar 04 2015	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Payment of Exercise	F	7.96	7,542	60,034	15,364	22.9 K to 15.4 K (-32.93 %)
Mar 04 2015	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Buy	M	7.96	22,906	182,332	22,906	0 to 22.9 K
Apr 03 2014	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	4.63	125,000	578,750	125,000
Dec 03 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	5.79	11,666	67,546	20	11.7 K to 20 (-99.83 %)
Nov 15 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	5.79	200	1,158	11,686	11.9 K to 11.7 K (-1.68 %)
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	M	3.06	30,000	91,800	30,000
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	M	3.01	13,884	41,791	9,375
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	M	3.01	14,241	42,865	23,259
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	M	2.74	12,500	34,250	12,500
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	7.03	43,884	308,469	11,886	55.8 K to 11.9 K (-78.69 %)
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Buy	M	3.06	30,000	91,800	55,770	25.8 K to 55.8 K (+116.41 %)
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Buy	M	3.01	13,884	41,791	25,770	11.9 K to 25.8 K (+116.81 %)
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	7.00	31,500	220,635	11,886	43.4 K to 11.9 K (-72.60 %)
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Buy	M	3.01	14,241	42,865	43,386	29.1 K to 43.4 K (+48.86 %)
Aug 02 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Buy	M	2.74	12,500	34,250	29,145	16.6 K to 29.1 K (+75.10 %)
Jul 25 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	M	3.75	4,759	17,846	0
Jul 25 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	M	2.74	5,000	13,700	25,000
Jul 25 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Buy	M	3.75	4,759	17,846	16,645	11.9 K to 16.6 K (+40.04 %)
Jul 25 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	6.50	5,000	32,500	11,886	16.9 K to 11.9 K (-29.61 %)
Jul 25 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Buy	M	2.74	5,000	13,700	16,886	11.9 K to 16.9 K (+42.07 %)
Apr 24 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	M	2.74	20,000	54,800	30,000
Apr 24 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	D	6.52	20,000	130,400	11,886	31.9 K to 11.9 K (-62.72 %)
Apr 24 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Buy	M	2.74	20,000	54,800	31,886	11.9 K to 31.9 K (+168.27 %)
Apr 24 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	M	2.74	20,000	54,800	30,000
Apr 24 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	D	6.52	20,000	130,400	11,886	31.9 K to 11.9 K (-62.72 %)
Apr 24 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Buy	M	2.74	20,000	54,800	31,886	11.9 K to 31.9 K (+168.27 %)
Apr 01 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	4.91	80,000	392,800	80,000
Apr 01 2013	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	4.91	80,000	392,800	80,000
Oct 09 2012	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	5.69	2,357	13,401	0	2.4 K to 0 (-100.00 %)
Oct 09 2012	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	5.69	26,190	148,911	11,886	38.1 K to 11.9 K (-68.78 %)
Oct 05 2012	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Grant	A	0.00	11,886	0	38,076	26.2 K to 38.1 K (+45.38 %)
Apr 03 2012	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	3.40	75,000	255,000	75,000
Oct 04 2011	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Grant	A	0.00	2,357	0	2,357	0 to 2.4 K
Oct 04 2011	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Grant	A	0.00	26,190	0	26,190	0 to 26.2 K
Apr 05 2011	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	3.06	1,250	3,825	1,250
Apr 05 2011	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	3.06	60,000	183,600	60,000
Apr 05 2011	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	3.30	356	1,175	0	356 to 0 (-100.00 %)
Jan 12 2011	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	3.30	2,366	7,808	356	2.7 K to 356 (-86.92 %)
Jan 12 2011	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	3.30	593	1,957	2,722	3.3 K to 2.7 K (-17.89 %)
Jan 06 2011	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	3.25	24,039	78,127	0	24 K to 0 (-100.00 %)
Oct 06 2010	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	3.29	20,067	66,020	24,039	44.1 K to 24 K (-45.50 %)
Oct 06 2010	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Grant	A	0.00	2,065	0	3,315	1.3 K to 3.3 K (+165.20 %)
Oct 06 2010	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Grant	A	0.00	24,039	0	44,106	20.1 K to 44.1 K (+119.79 %)
Aug 04 2010	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	3.25	3,479	11,307	20,067	23.5 K to 20.1 K (-14.78 %)
Aug 04 2010	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Sell	S	3.25	2,840	9,230	23,546	26.4 K to 23.5 K (-10.76 %)
Apr 01 2010	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	2.74	1,050	2,877	1,050
Apr 01 2010	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	2.74	50,000	137,000	50,000
Oct 06 2009	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Grant	A	0.00	1,250	0	1,250	0 to 1.3 K
Oct 06 2009	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Grant	A	0.00	20,067	0	26,386	6.3 K to 26.4 K (+317.57 %)
May 01 2009	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	3.01	37,500	112,875	37,500
Sep 11 2008	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP, General Counsel	Option Exercise	A	6.22	37,500	233,250	37,500
Aug 08 2005	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP AND GENERAL COUN ...	Option Exercise	A	6.51	60,000	390,600	60,000
Aug 03 2004	ARRY	ARRAY BIOPHARMA IN ...	MOORE JOHN R	VP AND GENERAL COUN ...	Option Exercise	A	6.68	10,503	70,160	10,503

Page: 1